A network for cancer clinical trials at the University of Rochester
Rochester Network Lead Academic Participating Site
This study is all about helping cancer patients by testing new treatments in clinical trials at the University of Rochester's Wilmot Cancer Institute, where a team of experts works together to find better ways to fight cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11250429 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer clinical trials through the University of Rochester's Wilmot Cancer Institute, which serves as a Lead Academic Site for the National Cancer Institute's National Clinical Trials Network. The program aims to develop and conduct late-phase cancer clinical trials, leveraging a multidisciplinary approach that includes experts from various medical fields. By utilizing extensive tissue banking and correlative studies, the research seeks to improve the understanding of cancer biology and the effectiveness of novel therapeutic strategies. Patients may have the opportunity to participate in cutting-edge clinical trials that could lead to new treatment options.
Who could benefit from this research
Good fit: Ideal candidates for participation include adults diagnosed with various types of cancer who are seeking advanced treatment options.
Not a fit: Patients with non-cancerous conditions or those not eligible for clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with access to innovative cancer treatments and improve overall outcomes.
How similar studies have performed: Previous research has shown success in similar cancer clinical trial networks, indicating a strong potential for impactful outcomes.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Barr, Paul M — University of Rochester
- Study coordinator: Barr, Paul M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.